Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Patrick Kenney

Surgery Sparks, NV Doctor of Osteopathy

NPI 1538142690 CMS profile 296683

2385 E Prater Way Ste 205, Sparks, NV 89434

Open in the dashboard

General payments

$419,828

705 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Patrick Kenney of Sparks, NV is reported in the CMS Open Payments database as having received $419,828 across 705 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $41,312 69
2024 General $36,050 61
2023 General $59,143 105
2022 General $79,948 120
2021 General $63,658 81
2020 General $63,154 129
2019 General $76,563 140

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Patrick Kenney
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Patrick Kenney were reported at $41,312. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Patrick Kenney Surgery median Middle half National median
2019 $76,563 $253 $82–$1,521 $163
2020 $63,154 $131 $40–$706 $114
2021 $63,658 $168 $50–$904 $132
2022 $79,948 $224 $76–$1,218 $149
2023 $59,143 $253 $82–$1,255 $160
2024 $36,050 $279 $90–$1,381 $164
2025 $41,312 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Intuitive Surgical, Inc. $412,382 651 payments
  2. Davol Inc. $2,400 14 payments
  3. Medtronic USA, Inc. $2,160 9 payments
  4. Stryker Corporation $1,077 5 payments
  5. KCI USA, Inc $642 7 payments
  6. C. R. Bard, Inc. & Subsidiaries $369 2 payments
  7. Smith+Nephew, Inc. $224 4 payments
  8. Solventum Corporation $220 4 payments
  9. Baxter Healthcare $135 2 payments
  10. Axonics Modulation Technologies, Inc. $77 2 payments
  11. Other $142 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $279,059 113 payments
  2. Travel and Lodging $99,641 418 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $24,695 22 payments
  4. Food and Beverage $16,423 151 payments
  5. Gift $9 1 payment
Products named General payments · program years 2019–2025
  1. Da Vinci Surgical System $408,082 647 payments
  2. DAVINCI XI $2,500 2 payments
  3. PlasmaBlade $2,093 7 payments
  4. DA VINCI SP $1,800 2 payments
  5. PHASIX $1,757 11 payments
  6. Phasix Mesh $776 2 payments
  7. 1688 HD 3 CHIP CAMERA $754 2 payments
  8. VAC VERAFLO CLEANSE CHOICE $605 3 payments
  9. PREVENA $604 5 payments
  10. VAC VERAFLO $596 2 payments
  11. Other $2,976 36 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

19

Median for General Surgery: 59

Drug cost

$25

Median for General Surgery: $393

Branded share of claims

0%

Median for General Surgery: 28.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 19 $25

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 15,891 Part D prescribers listed as General Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 42 billing codes

Paid by Medicare

$45,245

Medicare's payments for the services billed

Medicare patients

96

Average age 74

Services billed

198

51 women, 45 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 50%
Depression 42%
Diabetes 41%
Chronic kidney disease 31%
Atrial fibrillation 30%
COPD 24%
Ischemic heart disease 22%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

705 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in Nevada

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record